
Sign up to save your podcasts
Or


In this episode of the Avalere Health Essential Voice, we welcome leaders from the National Alliance of State & Territorial AIDS Directors (NASTAD) to discuss state HIV policies and barriers to ending the HIV epidemic in the US.
In this episode of the Avalere Health Essential Voice, we welcome Carl Schmid, Executive Director at the HIV + Hepatitis Policy Institute, to commemorate World AIDS Day on December 1.
In this episode of Avalere Health Essential Voice, our experts continue their discussion on channel strategy development for bringing a drug to market.
Tune into Part 1 here: https://avalere.com/podcasts/navigating-distribution-and-third-party-logistics-part-i
Tune into Part 2 here: https://avalere.com/podcasts/navigating-distribution-and-third-party-logistics-part-ii
In this episode of Avalere Health Essential Voice, our experts welcome leaders from Gilead Sciences and Jazz Pharmaceuticals to discuss channel distribution strategy.
Tune into Part 1 here: https://avalere.com/podcasts/navigating-distribution-and-third-party-logistics-part-i
In this episode of Avalere Health Essential Voice, the fifth and final in our Medicare Part D miniseries, our experts discuss the Center for Medicare & Medicaid Innovation (CMMI) and where we can anticipate some activity in the coming year, particularly as it relates to the Part D program.
In this episode of Avalere Health Essential Voice, the fourth in our Medicare Part D miniseries, our experts discuss key elements of the legislative process including budget neutrality and congressional scoring.
In this episode of Avalere Health Essential Voice, the third in our Medicare Part D miniseries, our experts discuss policy changes and the impact on market access.
In this episode of Avalere Health Essential Voice, the second in our Medicare Part D miniseries, our experts discuss how health plans make decisions within Part D.
In this episode of the Avalere Health Essential Voice Disease Education series, our experts discuss the need for patient support in cell and gene therapies and the ways in which various stakeholders provide it.
In this episode of Avalere Health Essential Voice, the first in our Medicare Part D miniseries, our experts discuss Part D trends and pressures in the evolving drug pricing environment.
From the publisher's feed